Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme
Clinical trial NCT03347097 · UNKNOWN
Trial details
- NCT number
- NCT03347097
- Sponsor
- Huashan Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2020-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.